Skip to main content
Caplight Logo









Ninsaúde

Ninsaúde

Private
CriciúmaHealthcare & Life Scienceshttps://ninsaude.com/en

Last Round

Seed

Nov 26, 2019

Total Funding Raised

$120,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Ninsaúde operates in Healthcare & Life Sciences and is based in Criciúma. Its latest recorded funding round was a Seed round in November 2019.

Ninsaúde is a healthtech company that provides a cloud-based electronic health record (EHR) and clinical management platform for medical practices and healthcare franchise networks.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Vertical SaaS, Telemedicine, Patient Engagement, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Payment Processing Fee

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ninsaúde Comparables

Compare Ninsaúde with similar companies based on industry and business-model similarity.

Ninsaúde comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GestãoDS
90%
App Health
89%
Salutho
87%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ninsaúde Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 26, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Manuela Corrêa

CFO

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 11, 2026

    Monthly visitors increased 59% MoM.

  • Apr 15, 2026

    Monthly visitors grew 80% MoM, from 34.5K to 62.3K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Ninsaúde Filings

Explore SEC and related filing metadata, where available.

Ninsaúde filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ninsaúde's valuation, stock price, and market status.

Is Ninsaúde a public or private company?

Ninsaúde is a private company.

What is the current stock price of Ninsaúde?

Ninsaúde is a private company, so its shares have no public market price. Caplight tracks Ninsaúde's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ninsaúde worth (valuation)?

Valuation information for Ninsaúde is not publicly available.

Can I buy Ninsaúde stock?

Ninsaúde shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ninsaúde's last funding round?

Ninsaúde's most recent funding round was Seed on November 26, 2019.

Who are the main investors in Ninsaúde?

Investor information for Ninsaúde is not publicly disclosed.

Will Ninsaúde IPO soon?

No public IPO plans have been announced for Ninsaúde.

How can I track Ninsaúde secondary market activity?

Caplight tracks bids, offers, and trades in Ninsaúde's shares on secondary markets.

Firmographic Details

HeadquartersCriciúma
Employee Range15
Year Founded2010
Last FundingNov 26, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?